Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review

被引:59
作者
Downey, Colum [1 ]
机构
[1] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland
关键词
adalimumab; etanercept; infection; infliximab; rheumatoid arthritis; ANTITUMOR-NECROSIS-FACTOR; VISCERAL LEISHMANIASIS INFECTION; RECEIVING CONCOMITANT METHOTREXATE; MYCOBACTERIUM-CHELONAE INFECTION; SEPTIC ARTHRITIS; LISTERIA-MONOCYTOGENES; BACTERIAL-INFECTIONS; MONOCLONAL-ANTIBODY; FACTOR INHIBITORS; BRITISH-SOCIETY;
D O I
10.1111/1756-185X.12659
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this review is to establish whether there is a significantly increased incidence of serious infections during treatment for rheumatoid arthritis (RA) with etanercept, infliximab or adalimumab, to determine the background risk of serious infection in RA patients without treatment with any biological therapy and to ascertain which organisms are involved in serious infections in RA patients while being treated with etanercept, infliximab or adalimumab. Randomised controlled trials (RCTs), meta-analyses of RCTs, Cochrane reviews, national registry articles and case reports were identified using PubMed/MEDLINE, The Cochrane Library and Google Scholar. The medical subject heading rheumatoid arthritis was combined with serious infection or infection or adverse drug events with each of the three reference biological therapies separately: etanercept, infliximab and adalimumab. These electronic searches were limited to human studies, adult studies, those published in the last 10years (2004-14) and in the English language. Studies which involved the tumor necrosis factor- inhibitors certolizumab pegol or golimumab were excluded. The background risk of serious infection appears to be approximately two-fold more than non-RA patients before any treatment with biological therapy. The national registries, which may represent the typical RA patient more accurately than clinical trials, suggest a small but significantly increased incidence of serious infection ranging 1.2-2.78 times that of control (treatment with methotrexate). Mycobacteria spp., Staphyloccus aureus, Listeria monocytogenes, Varicella zoster virus and Leishmania species (spp.) repeatedly appear in the case report literature and should be in the mind of the clinician faced with a serious infection in a RA patient with an unknown pathogen who is being treated with either etanercept, infliximab or adalimumab.
引用
收藏
页码:536 / 550
页数:15
相关论文
共 135 条
  • [91] Hemophagocytic Lymphohistiocytosis in a Rheumatoid Arthritis Patient Treated with Infliximab
    Oda, Yuzo
    Urushidani, Yoshinori
    Ooi, Shinji
    Endoh, Akira
    Nakamura, Rika
    Adachi, Koji
    Fukushima, Hiroko
    [J]. INTERNAL MEDICINE, 2012, 51 (06) : 655 - 657
  • [92] Salmonella septic arthritis following total knee arthroplasty for rheumatoid arthritis in a patient receiving etanercept
    Oe, Kenichi
    Wada, Takahiko
    Ohno, Hiroshi
    Kushida, Taketoshi
    Iida, Hirokazu
    [J]. JOURNAL OF ORTHOPAEDIC SCIENCE, 2011, 16 (02) : 258 - 262
  • [93] Oguri Tomoyo, 2010, Nihon Kokyuki Gakkai Zasshi, V48, P192
  • [94] Okubo Hikaru, 2005, Mod Rheumatol, V15, P62
  • [95] Does etanercept monotherapy enhance the risk of Listeria monocytogenes meningitis?
    Pagliano, P
    Attanasio, V
    Fusco, U
    Mohamed, DA
    Rossi, M
    Faella, FS
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (04) : 462 - 463
  • [96] Association of the TRAF1/C5 Locus With Increased Mortality, Particularly From Malignancy or Sepsis, in Patients With Rheumatoid Arthritis
    Panoulas, Vasilelos F.
    Smith, Jacqueline P.
    Nightingale, Peter
    Kitas, George D.
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (01): : 39 - 46
  • [97] Petrie A., 2009, MED STAT GLANCE, V3rd
  • [98] A postoperative infectious complication in a patient with rheumatoid arthritis treated with adalimumab
    Pfeiffer, M.
    Koeller, M.
    Wanivenhaus, A.
    Trieb, K.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2006, 65 (08): : 725 - 727
  • [99] Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept
    Rachapalli, Satish
    O'Daunt, Simon
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (03): : 987 - 987
  • [100] Candida albicans Infection of a Reverse-Polarity Shoulder Replacement in a Patient With Rheumatoid Arthritis Treated With Etanercept
    Radha, Sarkhell
    Siddiqui, Bobby Mobbassar
    Senevirathna, Shanaka
    Harrison, John W. K.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2012, 18 (06) : 323 - 323